Scientific news

UC San Diego to research CBD for anorexia, autism, schizophrenia, tremor

The studies, to be conducted by the University of California, San Diego (UCSD) Center for Medicinal Cannabis Research will focus on the use of cannabinoids as a treatment for anorexia nervosa, autism, essential tremor, and schizophrenia, and are all expected to launch in 2019

Father credits cannabidiol oil with boosting autistic son's quality of life

The father of an autistic teenager says cannabidiol oil has has opened up a new world for his son

Cannabinoid interventions for PTSD: Where to next?

This article makes the strengths and challenges of different potential cannabinoid treatments accessible to psychological researchers interested in cannabinoid therapeutics and aims to aid selection of appropriate tools for future clinical trials

Medicinal use of cannabis based products and cannabinoids

Use of these products may increase as new evidence arises and policy changes occur - here we review this emerging field

Drugs companies 'should be put under pressure' over clinical trials for medicinal cannabis

Baroness Blackwood said one of the main problems with the public accessing cannabis-based medicinal products was the lack of clinical trials to date

Can medicinal cannabis treat the tics in Tourette syndrome?

First Australian medicinal cannabis trial for the treatment of severe Tourette syndrome supported by the Lambert Initiative at University of Sydney

Clearing the air on cannabis

Rapid legalization, increasing use and conflicting laws are a confusing blend for employers and safety professionals attempting to set workplace policies about cannabis

The WIRED Guide to Cannabis

Everything you need to know about THC, CBD, terpenes, and the entourage effect

Why patients are still being denied legalised medical cannabis

Hospital trust bureaucracy and doctors’ ignorance are to blame for the lack of prescriptions for medical cannabis being issued on the NHS, despite its reclassification for medical use in November 2018

Impact of medical cannabis on patients with cancer enrolled in Minnesota's medical cannabis program

Minnesota’s medical cannabis program is unique, in that it routinely collects patient-reported scores on symptoms. This article focuses on changes in symptom severity reported by patients with cancer during their first 4 months of program participation